Search
Searching Content indexed under Patent by Adheesh Nargolkar ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Delhi High Court: Defendants Can Continue Sales Of Patent Infringing Product On Deposit Of Security
Recently, the Delhi High Court, in the matter of Communication Components Antenna Inc v Ace Technologies Corp. And Ors, directed the Defendants to deposit a bank guarantee of approximately INR 550 million ...
India
7 Aug 2019
2
Draft Patent (Amendment) Rules, 2018 Published For Objections And Suggestions
The Ministry of Commerce and Industry has published Draft Patent Rules, 2018 for objections and suggestions
India
11 Dec 2018
3
Delhi High Court Awards Damages And Costs In Addition To Royalty Fees In A Standard Essential Patent Infringement Suit
Recently, the Delhi High Court, in the matter of Koninklijke Philips Electronics N.V. (Plaintiff) v Rajesh Bansal and Ors (Defendants), after duly conducting and concluding a trial in the suit...
India
20 Jul 2018
4
Revised Guidelines For Examining Computer Related Inventions By The Patent Office Issued
The Indian Patent Office (IPO) has once again revisited the guidelines for examination of Computer Related Inventions (CRIs) and issued revised guidelines on 30 June 2017 (Revised Guidelines).
India
4 Jul 2017
5
The Patent (Amendment) Rules, 2016 Come Into Force
The Patent (Amendment) Rules, 2016 (Revised Rules) have come into force from 16 May 2016. The key highlights of the Revised Rules are broadly set out below...
India
20 May 2016
6
Issuance Of Revised Guidelines For Examining Computer Related Inventions By The Patent Office
The Indian Patent office (IPO) had earlier issued guidelines on 21 August 2015 to Patent Examiners relating to the examination of computer related inventions.
India
26 Feb 2016
7
Lee Pharma's Compulsory License Application For Saxagliptin Rejected By Indian Patent Office
In an order dated 19 January 2016 (Order), the Controller General of Patents and Trademarks rejected the application for Compulsory License for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
India
23 Jan 2016
8
Pfizer's Patent Application Relating To Rheumatoid Arthritis Drug (Tofacitinib) Rejected By Indian Patent Office
The Indian Patent Office has passed an order on 3 September 2015 rejecting patent application no. 991/MUMNP/2003 to Pfizer Products, Inc. for rheumatoid arthritis drug ‘Tofacitinib'.
India
10 Sep 2015
9
Compulsory License For Astrazeneca's Diabetes Management Drug Saxagliptin?
In a recent development, a compulsory license (CL) application has been filed for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
India
8 Jul 2015
Links to Result pages
 
1